Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase producing Enterobacteriaceae infections in France, 2009 to 2013

Eurosurveillance

Volumn 20, Issue 36, 2015, Pages

  Arnaud, I ^a   Maugat, S ^b   Jarlier, V ^c   Astagneau, P ^a,d   Bajolet, Odile ^e   Bertrand, Xavier ^e   Blanchard, Hervé ^e   Caillat Vallet, Emmanuelle ^e   Coignard, Bruno ^e   Dugravot, Lory ^e   Dumartin, Catherine ^e   Eveillard, Mathieu ^e   Fosse, Thierry ^e   Garreau, Nadine ^e   Glorion, Sophie ^e   Lacoste, Jessica ^e   Hoff, Olivier ^e   Marty, Nicole ^e   Parneix, Pierre ^e   Reyreaud, Emmanuelle ^e   Savey, Anne ^e   Sénéchal, Hélène ^e   Simon, Loïc ^e   Sousa, Elisabeth ^e   Trystram, David ^e   Vaux, Sophie ^e   more..

^a Regional Coordinating Center for Nosocomial Infection Control   (France)

^b INSTITUT DE VEILLE SANITAIRE   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d EHESP SCHOOL OF PUBLIC HEALTH   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; DISEASE SURVEILLANCE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FRANCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; INCIDENCE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; TEMPORAL ANALYSIS; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; EPIDEMIC; ESCHERICHIA COLI INFECTIONS; GENETICS; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; SECRETION (PROCESS); URINARY TRACT INFECTIONS;

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FRANCE; HUMANS; INCIDENCE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; URINARY TRACT INFECTIONS;

EID: 85000461350     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.36.30014     Document Type: Article

References (31)

1. ColodnerR, RockW, ChazanB, KellerN, GuyN, SakranW, et al. Risk factors for the development of extended-spectrum betalactamase- producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23(3):163-7. DOI: 10.1007/ s10096-003-1084-2 PMID: 14986159
2. StewardsonA, FankhauserC, De AngelisG, RohnerP, SafranE, SchrenzelJ, et al. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol. 2013;34(2):133-43. DOI: 10.1086/669086 PMID: 23295559
3. WegnerC, HübnerNO, GleichS, ThalmaierU, KrügerCM, KramerA. One-day point prevalence of emerging bacterial pathogens in a nationwide sample of 62 German hospitals in 2012 and comparison with the results of the one-day point prevalence of 2010.GMS Hyg Infect Control. 2013;8(1):Doc12. PMID: 23967398
4. National Contact Points for the ECDC pilot point prevalence survey,ZarbP, CoignardB, GriskevicieneJ, MullerA, VankerckhovenV, WeistK, et al. . The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.Euro Surveill. 2012;17(46):20316.PMID: 23171822
5. Reseau d'alerte, d'investigation et de surveillance des infections nosocomiales (RAISIN). Enquete nationale de prevalence des infections nosocomiales et des traitements anti-infectieux en etablissements de sante, France, maijuin 2012. Resultats. [2012 national prevalence survey of nosocomial infections and anti-infection treatments in healthcare facilities. May-June 2012. Results]. Saint-Maurice: Institut de veille sanitaire; 2013. [Accessed 2 Sep 2015]. French. Available from: http://www.invs.sante.fr/Publicationset- outils/Rapports-et-syntheses/Maladies-infectieuses/2013/ Enquete-nationale-de-prevalence-des-infectionsnosocomiales- et-des-traitements-anti-infectieux-enetablissements- de-sante-France-mai-juin-2012
6. GoulenokT, FerroniA, BilleE, LécuyerH, Join-LambertO, DescampsP, et al. Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization? J Hosp Infect. 2013;84(4):294-9. DOI: 10.1016/j.jhin.2013.04.018 PMID: 23846237
7. BirgandG, Armand-LefevreL, LolomI, RuppeE, AndremontA, LucetJC. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.Am J Infect Control. 2013;41(5):443-7. DOI: 10.1016/j. ajic.2012.05.015 PMID: 22998785
8. ValverdeA, CoqueTM, Sánchez-MorenoMP, RollánA, BaqueroF, CantónR. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.J Clin Microbiol. 2004;42(10):4769-75. DOI: 10.1128/ JCM.42.10.4769-4775.2004 PMID: 15472339
9. MDRB Surveillance National Steering Group (BMRRaisin), CarbonneA, ArnaudI, MaugatS, MartyN, DumartinC, BertrandX, et al. . National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience.J Antimicrob Chemother. 2013;68(4):954-9. DOI: 10.1093/jac/dks464 PMID: 23194721
10. Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France,JarlierV, TrystramD, Brun- BuissonC, FournierS, CarbonneA, MartyL, et al. . Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med. 2010;170(6):552-9. DOI: 10.1001/ archinternmed.2010.32 PMID: 20308642
11. Toronto ESBL Working Group,LoweCF, KatzK, McGeerAJ, MullerMP. Efficacy of admission screening for extendedspectrum beta-lactamase producing Enterobacteriaceae.PLoS ONE. 2013;8(4):e62678. DOI: 10.1371/journal.pone.0062678 PMID: 23638132
12. GiboldL, RobinF, TanRN, DelmasJ, BonnetR. Four-year epidemiological study of extended-spectrum β-lactamaseproducing Enterobacteriaceae in a French teaching hospital. Clin Microbiol Infect. 2014;20(1):O20-6. DOI: 10.1111/1469-0691.12321 PMID: 23927626
13. KassakianSZ, MermelLA. Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria.Antimicrob Resist Infect Control. 2014;3(1):9. DOI: 10.1186/2047-2994-3-9 PMID: 24666610
14. SoussyCJ, CarretG, CavalloJD, ChardonH, ChidiacC, ChoutetP, et al. [Antibiogram Committee of the French Microbiology Society. Report 2000-2001]. Pathol Biol (Paris). 2000;48(9):832-71.PMID: 11141919
15. French Society of Microbiology (SFM). Comité de l’antibiogramme de la Société Française de Microbiologie. Recommandation 2015. [Committee for Antimicrobial Testing of the French Society of Microbiology. 2015 recommendations]. Paris: SFM. [Accessed 2 Sep 2015]. French. Available from: http://www.sfm-microbiologie.org/UserFiles/files/casfm/ CASFMV2_220715.pdf
16. JarlierV, NicolasMH, FournierG, PhilipponA. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.Rev Infect Dis. 1988;10(4):867-78. DOI: 10.1093/clinids/10.4.867 PMID: 3263690
17. Lin M, Weinstein RA, Hayden MK. Multiply drug-resistant pathogens: epidemiology and control. In: Jarvis WR, editor. Bennett & Brachman's hospital infections. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 193-222.
18. ReichF, AtanassovaV, KleinG. Extended-spectrum β-lactamaseand AmpC-producing enterobacteria in healthy broiler chickens, Germany.Emerg Infect Dis. 2013;19(8):1253-9. DOI: 10.3201/eid1908.120879 PMID: 23876576
19. GeserN, StephanR, HächlerH. Occurrence and characteristics of extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk.BMC Vet Res. 2012;8(1):21. DOI: 10.1186/1746- 6148-8-21 PMID: 22397509
20. van HoekAH, SchoulsL, van SantenMG, FlorijnA, de GreeffSC, van DuijkerenE. Molecular characteristics of extended spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community.PLoS ONE. 2015;10(6):e0129085. DOI: 10.1371/journal.pone.0129085 PMID: 26029910
21. RAISIN and Expert Laboratories Groups,VauxS, CarbonneA, ThioletJM, JarlierV, CoignardB. Emergence of carbapenemase producing Enterobacteriaceae in France, 2004 to 2011.Euro Surveill. 2011;16(22):19880.PMID: 21663708
22. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance interactive database (EARS-Net). Stockholm: ECDC. [Accessed 2 Sep 2015]. Available from: http://ecdc.europa.eu/en/healthtopics/antimicrobial_ resistance/database/Pages/database.aspx#sthash.goMy0HLp. dpuf
23. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2013. Available from: http://ecdc.europa.eu/en/publications/Publications/ antimicrobial-resistance-surveillance-europe-2012.pdf
24. JonesRN, FlontaM, GurlerN, CepparuloM, MendesRE, CastanheiraM. Resistance surveillance program report for selected European nations (2011).Diagn Microbiol Infect Dis. 2014;78(4):429-36. DOI: 10.1016/j.diagmicrobio.2013.10.008 PMID: 24440509
25. Institut de Veille Sanitaire (InVS). Signalement externe des infections nosocomiales. E-SIN. [External reporting of nosocomial infections. E-SIN]. Saint Maurice: InVS. [Accessed 2 Sep 2015]. Available from: http://www.invs. sante.fr/Dossiers-thematiques/Maladies-infectieuses/ Infections-associees-aux-soins/Signalement-et-alertes/ Signalement-externe-des-infections-nosocomiales
26. de KrakerME, WolkewitzM, DaveyPG, KollerW, BergerJ, NaglerJ, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother. 2011;66(2):398-407. DOI: 10.1093/jac/dkq412 PMID: 21106563
27. Institut de Veille Sanitaire (InVS). Surveillance des bacteries multiresistantes dans les etablissements de sante francais. Reseau BMR-Raisin - Donnees 2012, France 01-01-2014. [Surveillance of multidrug-resistant bacteria in Ffrench health care facilities. MRO RAISIN network. 2012 results. France, 01-01-2014]. Saint Maurice: InVS. [Accessed 3 Sep 2015]. French. Available from: http://www.invs.sante.fr/pmb/ invs/%28id%29/PMB_12101
28. CastanheiraM, FarrellSE, KrauseKM, JonesRN, SaderHS. Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups.Antimicrob Agents Chemother. 2014;58(2):833-8. DOI: 10.1128/AAC.01896- 13 PMID: 24247134
29. Fernandes R, Amador P, Oliveira C, Prudencio C. Molecular Characterization of ESBL-Producing Enterobacteriaceae in Northern Portugal. ScientificWorldJournal. 2014;2014:782897. doi: 10.1155/2014/782897
30. Institut de Veille Sanitaire (InVS). Episodes impiquant des entérobactéries productrices de carbapénèmases en France. Situation épidémiologique du 4 mars 2015. [Episodes involving carbapenemases producing enterobacteria in France. Epidemiological situation of March 4, 2015]. Saint Maurice: InVS. [Accessed 2 Sep 2015]. Available from: http://www.invs.sante.fr/Dossiers-thematiques/ Maladies-infectieuses/Infections-associees-aux-soins/ Surveillance-des-infections-associees-aux-soins-IAS/ Enterobacteries-productrices-de-carbapenemases-EPC/ Episodes-impliquant-des-enterobacteries-productrices-decarbapenemases- en-France.-Situation-epidemiologique-du-4- mars-2015
31. Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP. Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int. 2014;2014:305784.